免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

ECG-AI 低射血量分數(LEF)12導電路演算法(1010)

K 號:K250652 · 2025-07-28

申請人Anumana, Inc.
決定日期2025-07-28
產品代碼QYE
諮詢委員會履歷
決定相當於

器材摘要

ECG-AI Low Ejection Fraction (LEF) 12-Lead algorithm (1010) is the device name listed in this FDA 510(k) record. The listed applicant is Anumana, Inc.. It received FDA 510(k) clearance on 2025-07-28 under 510(k) number K250652. The device is classified under product code QYE. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the ECG-AI Low Ejection Fraction (LEF) 12-Lead algorithm (1010)?

ECG-AI Low Ejection Fraction (LEF) 12-Lead algorithm (1010) is a medical device that received FDA 510(k) clearance on 2025-07-28. The listed applicant is Anumana, Inc.. The 510(k) number is K250652.

When did ECG-AI Low Ejection Fraction (LEF) 12-Lead algorithm (1010) receive FDA 510(k) clearance?

ECG-AI Low Ejection Fraction (LEF) 12-Lead algorithm (1010) received FDA 510(k) clearance on 2025-07-28, under 510(k) number K250652.

Who is the listed applicant for ECG-AI Low Ejection Fraction (LEF) 12-Lead algorithm (1010)?

The FDA 510(k) record lists Anumana, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ECG-AI Low Ejection Fraction (LEF) 12-Lead algorithm (1010)?

The FDA product code for ECG-AI Low Ejection Fraction (LEF) 12-Lead algorithm (1010) is QYE.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Anumana, Inc. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:QYE)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑